Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data.
Adolescents
Anxiety
Depression
Health insurance data
Juvenile idiopathic arthritis
Mental comorbidities
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
05 Jan 2024
05 Jan 2024
Historique:
received:
02
11
2023
accepted:
17
12
2023
medline:
6
1
2024
pubmed:
6
1
2024
entrez:
5
1
2024
Statut:
epublish
Résumé
Studies on prevalence rates of mental comorbidities in patients with juvenile idiopathic arthritis (JIA) have reported varying results and provided limited information on related drugs. The purpose of this study was to determine the prevalence of selected mental health diagnoses and the range of associated drug prescriptions among adolescents and young adults (AYA) with JIA compared with general population controls. Nationwide statutory health insurance data of the years 2020 and 2021 were used. Individuals aged 12 to 20 years with an ICD-10-GM diagnosis of JIA in ≥ 2quarters, treated with disease-modifying antirheumatic drugs and/or glucocorticoids were included. The frequency of selected mental health diagnoses (depression, anxiety, emotional and adjustment disorders) was determined and compared with age- and sex-matched controls. Antirheumatic, psychopharmacologic, psychiatric, and psychotherapeutic therapies were identified by Anatomical Therapeutic Chemical (ATC) codes and specialty numbers. Based on data from 628 AYA with JIA and 6270 controls, 15.3% vs. 8.2% had a diagnosed mental health condition, with 68% vs. 65% receiving related drugs and/or psychotherapy. In both groups, depression diagnosis became more common in older teenagers, whereas emotional disorders declined. Females with and without JIA were more likely to have a mental health diagnosis than males. Among AYA with any psychiatric diagnosis, 5.2% (JIA) vs. 7.0% (controls) received psycholeptics, and 25% vs. 27.3% psychoanaleptics. Selected mental health conditions among 12-20-year-old JIA patients are diagnosed more frequently compared to general population. They tend to occur more frequently among females and later in childhood. They are treated similarly among AYA regardless of the presence of JIA.
Sections du résumé
BACKGROUND
BACKGROUND
Studies on prevalence rates of mental comorbidities in patients with juvenile idiopathic arthritis (JIA) have reported varying results and provided limited information on related drugs. The purpose of this study was to determine the prevalence of selected mental health diagnoses and the range of associated drug prescriptions among adolescents and young adults (AYA) with JIA compared with general population controls.
FINDINGS
RESULTS
Nationwide statutory health insurance data of the years 2020 and 2021 were used. Individuals aged 12 to 20 years with an ICD-10-GM diagnosis of JIA in ≥ 2quarters, treated with disease-modifying antirheumatic drugs and/or glucocorticoids were included. The frequency of selected mental health diagnoses (depression, anxiety, emotional and adjustment disorders) was determined and compared with age- and sex-matched controls. Antirheumatic, psychopharmacologic, psychiatric, and psychotherapeutic therapies were identified by Anatomical Therapeutic Chemical (ATC) codes and specialty numbers. Based on data from 628 AYA with JIA and 6270 controls, 15.3% vs. 8.2% had a diagnosed mental health condition, with 68% vs. 65% receiving related drugs and/or psychotherapy. In both groups, depression diagnosis became more common in older teenagers, whereas emotional disorders declined. Females with and without JIA were more likely to have a mental health diagnosis than males. Among AYA with any psychiatric diagnosis, 5.2% (JIA) vs. 7.0% (controls) received psycholeptics, and 25% vs. 27.3% psychoanaleptics.
CONCLUSIONS
CONCLUSIONS
Selected mental health conditions among 12-20-year-old JIA patients are diagnosed more frequently compared to general population. They tend to occur more frequently among females and later in childhood. They are treated similarly among AYA regardless of the presence of JIA.
Identifiants
pubmed: 38183044
doi: 10.1186/s12969-023-00948-y
pii: 10.1186/s12969-023-00948-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
10Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01EC1902A
Informations de copyright
© 2024. The Author(s).
Références
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.
pubmed: 14760812
Petty RE, Laxer RM, Wedderburn LR. Juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier; 2016. p. 188–204.
doi: 10.1016/B978-0-323-24145-8.00015-6
Fair DC, Rodriguez M, Knight AM, Rubenstein TB. Depression and anxiety in patients with juvenile idiopathic arthritis: current insights and impact on quality of life, a systematic review. Open Access Rheumatol Res Rev. 2019;11:237–52.
Szulczewski L, Mullins LL, Bidwell SL, Eddington AR, Pai ALH. Meta-analysis: care giver and youth uncertainty in pediatric chronic illness. J Pediatr Psychol. 2016;42:395–421.
doi: 10.1093/jpepsy/jsw097
Davis AM, Graham TB, Zhu Y, McPheeters ML. Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus. 2018;27:1532–41.
doi: 10.1177/0961203318779710
pubmed: 29954282
pmcid: 6084794
Christie D, Viner R. Adolescent development. BMJ. 2005;330:301–4.
doi: 10.1136/bmj.330.7486.301
pubmed: 15695279
pmcid: 548185
Pedersen MJ, Høst C, Hansen SN, Deleuran BW, Bech BH. Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic Arthritis: A National Matched Cohort Study. J Rheumatol. 2023. Epub ahead of print. PMID: 37321635.
Delcoigne B, Horne A, Reutfors J, Askling J. Risk of psychiatric disorders in Juvenile idiopathic arthritis: population- and sibling-controlled cohort and cross-sectional analyses. ACR Open Rheumatol. 2023;5:277–84.
doi: 10.1002/acr2.11549
pubmed: 37170883
pmcid: 10184008
Roemer J, Klein A, Horneff G. Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis. Rheumatol Int. 2023;43:1497–505.
doi: 10.1007/s00296-023-05323-4
pubmed: 37039854
pmcid: 10261240
Li L, Merchant M, Gordon S, Lang B, Ramsey S, Huber AM, Gillespie J, Lovas D, Stringer E. High Rates of symptoms of major depressive disorder and panic disorder in a Canadian sample of adolescents with Juvenile idiopathic arthritis. J Rheumatol. 2023;50:804–8.
doi: 10.3899/jrheum.220067
pubmed: 36521911
Statista. Bevölkerung - Zahl der Einwohner in Deutschland nach relevanten Altersgruppen am 31. Dezember 2022. https://de.statista.com/statistik/daten/studie/1365/umfrage/bevoelkerung-deutschlands-nach-altersgruppen . Accessed 18 Aug 2023.
World Health Organization. ATC/DDD Toolkit. https://www.who.int/tools/atc-ddd-toolkit/about . Accessed 13 Aug 2023.
Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885.
doi: 10.1371/journal.pmed.1001885
pubmed: 26440803
pmcid: 4595218
Kyllönen MS, Ebeling H, Kautiainen H, Puolakka K, Vähäsalo P. Psychiatric disorders in incident patients with juvenile idiopathic arthritis - a case-control cohort study. Pediatr Rheumatol Online J. 2021;19:105.
doi: 10.1186/s12969-021-00599-x
pubmed: 34215280
pmcid: 8252279
Bomba M, Meini A, Molinaro A, Cattalini M, Oggiano S, Fazzi E, et al. Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. Rheumatol Int. 2013;33:2045–52.
doi: 10.1007/s00296-013-2685-4
pubmed: 23392772
Memari AH, Chamanara E, Ziaee V, Kordi R, Raeeskarami SR. Behavioral problems in juvenile idiopathic arthritis: a controlled study to examine the risk of psychopathology in a chronic pediatric disorder. Int J Chronic Dis. 2016;2016:5726236.
pubmed: 27656678
pmcid: 5021472
Oommen PT, Klotsche J, Dressler F, Foeldvari I, Foell D, Horneff G, et al. Frequency of depressive and anxious symptoms in patients with juvenile idiopathic arthritis (JIA) – Data from the Inception Cohort of Newly diagnosed patients with JIA (ICON). Ann Rheum Dis. 2022;81:143.
doi: 10.1136/annrheumdis-2022-eular.3925
Tarakci E, Yeldan I, Kaya Mutlu E, Baydogan SN, Kasapcopur O. The relationship between physical activity level, anxiety, depression, and functional ability in children and adolescents with juvenile idiopathic arthritis. Clin Rheumatol. 2011;30:1415–20.
doi: 10.1007/s10067-011-1832-0
pubmed: 21887489
Fair DC, Nocton JJ, Panepinto JA, Yan K, Zhang J, Rodriguez M, et al. Anxiety and depressive symptoms in juvenile idiopathic arthritis correlate with pain and stress using PROMIS measures. J Rheumatol. 2022;49:74–80.
doi: 10.3899/jrheum.210101
pubmed: 34334368
Berthold E, Dahlberg A, Jöud A, Tydén H, Månsson B, Kahn F, et al. The risk of depression and anxiety is not increased in individuals with juvenile idiopathic arthritis – results from the south-Swedish juvenile idiopathic arthritis cohort. Pediatr Rheumatol Online J. 2022;20:114.
doi: 10.1186/s12969-022-00765-9
pubmed: 36494819
pmcid: 9733298
Sauer K, Barkmann C, Klasen F, Bullinger M, Glaeske G, Ravens-Sieberer U. How often do German children and adolescents show signs of common mental health problems? Results from different methodological approaches-a cross-sectional study. BMC Public Health. 2014;14:229.
doi: 10.1186/1471-2458-14-229
pubmed: 24597565
pmcid: 3996039
Hanns L, Cordingley L, Galloway J, Norton S, Carvalho LA, Christie D, et al. Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the childhood arthritis prospective study. Rheumatology (Oxford). 2018;57:1381–9.
doi: 10.1093/rheumatology/key088
pubmed: 29697850
Sengler C, Milatz F, Minden K. Mental health in children and adolescents with rheumatic diseases. Screening as an integral part of care. Arthritis und Rheuma. 2022;42:381–8.
Albrecht K, Binder S, Minden K, Poddubnyy D, Regierer AC, Strangfeld A, Callhoff J. Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. Z Rheumatol 2023. https://doi.org/10.1007/s00393-022-01305-2 . Online ahead of print.